Sec Form 4 Filing - Arthur Michael J @ Airsculpt Technologies, Inc. - 2026-01-24

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Arthur Michael J 2. Issuer Name and Ticker or Trading Symbol Airsculpt Technologies, Inc. [ AIRS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Financial Officer (Last) (First) (Middle) C/O AIRSCULPT TECHNOLOGIES, INC., 1111 LINCOLN ROAD, SUITE 802 3. Date of Earliest Transaction (MM/DD/YY) 01/24/2026 (Street) MIAMI BEACH, FL33139 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, $0.001 Par Value 01/24/2026 A( 1 ) 147,059 A $ 0 147,059 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Performance Stock Units ( 2 ) 01/24/2026 A 147,059 ( 2 ) 01/24/2029 Common Stock 147,059 $ 0 147,059 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Arthur Michael J C/O AIRSCULPT TECHNOLOGIES, INC. 1111 LINCOLN ROAD, SUITE 802 MIAMI BEACH, FL33139 Chief Financial Officer Signatures /s/ Thomas P. Conaghan, Attorney-in-Fact 01/27/2026 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The Reporting Person was granted an award of 147,059 Restricted Stock Units ("RSUs") on January 24, 2026 pursuant to the 2021 Equity Incentive Plan of AirSculpt Technologies, Inc. (the "Company"). Under the terms of the RSU award, the RSUs will vest in three equal annual installments, subject to the Reporting Person's continued employment with the Company, beginning on January 24, 2027. ( 2 )The Reporting Person was granted an award of 147,059 Performance Stock Units ("PSUs") on January 24, 2026 pursuant to the Company's 2021 Equity Incentive Plan. Each PSU represents a contingent right to receive one share of Company common stock. Under the terms of the PSU award, the PSUs will vest subject to a relative total shareholder return performance goal over a three-year performance period relative to the total shareholder return of the S&P Health Care Select Industry Index, with performance ranging from 0% to 200% of the target award, as determined at the end of the three-year performance period.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.